Header image
Mistrík Martin Ph.D.
Journals
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Haematologica.
2020,
106(2),
601-604,
ISSN: 0390-6078,
PMID: 32381580,
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Oncogene.
2019,
38(40),
6711-6722,
ISSN: 0950-9232,
PMID: 31391554,
Open positions
| Project: | DNA damage signaling in the cellular response to stress |
|---|---|
| Supervisors: | Mistrík Martin Ph.D. |
| Available: | 1 |
| Intended for: | Doctoral training |
| Summary: | 1 place in full-time study |
| Project: | Cellular stress in health and disease |
|---|---|
| Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. |
| Available: | 3 |
| Intended for: | Doctoral training |
| Project: | Identification of cellular stress pathways essential for cancer cell survival |
|---|---|
| Supervisors: | Mistrík Martin Ph.D. |
| Available: | 1 |
| Intended for: | Doctoral training |
| Summary: | 1 full-time position |